Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thyroid Hormone for Insulin Receptor Mutations
NCT02457897Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Apr 2015
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liothyronine in diabetes mellitus (DM), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Apr 2015; status: completed.
02
Drugs
liothyronine
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT02457897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02457897.